Dermapharm Holding SE (DMP) — Cash Flow Quality Index
Latest as of March 2026:
0.87x
Dermapharm Holding SE (DMP) has a Cash Flow Quality Index of 0.87x as of March 2026. Operating cash flow of €39.49 Million is below net income of €45.20 Million, suggesting accrual-heavy earnings not yet converted to cash. Explore DMP cash flow to debt ratio to assess how comfortably operating cash covers total debt obligations.
Cash Flow Quality Index
0.87x
Operating CF / Net Income
Operating Cash Flow
€39.49 Million
EUR
Net Income
€45.20 Million
EUR
Data as of
Mar 2026
Most recent filing
Dermapharm Holding SE Cash Flow Quality Index (2014–2025)
Historical Cash Flow Quality Index for Dermapharm Holding SE across 12 annual periods. Values consistently above 1.0x indicate high-quality earnings. For the full cash flow conversion analysis, see DMP cash flow conversion.
Annual Cash Flow Quality Index for Dermapharm Holding SE (2014–2025)
Year-by-year earnings quality comparison for Dermapharm Holding SE.
| Year | Quality Index | Operating CF (EUR) | Net Income | YoY Change |
|---|---|---|---|---|
| 2025 | 1.37x | €181.51 Million | €132.41 Million | ▲ +17.1% |
| 2024 | 1.17x | €201.38 Million | €172.00 Million | ▼ -66.7% |
| 2023 | 3.52x | €219.42 Million | €62.37 Million | ▲ +163.7% |
| 2022 | 1.33x | €288.53 Million | €216.30 Million | ▲ +56.1% |
| 2021 | 0.85x | €250.37 Million | €292.98 Million | ▼ -18.3% |
| 2020 | 1.05x | €131.10 Million | €125.28 Million | ▲ +14.5% |
| 2019 | 0.91x | €100.61 Million | €110.07 Million | ▼ -56.8% |
| 2018 | 2.12x | €159.13 Million | €75.23 Million | ▲ +89.6% |
| 2017 | 1.12x | €86.74 Million | €77.74 Million | ▼ -75.2% |
| 2016 | 4.50x | €76.78 Million | €17.06 Million | ▲ +43.7% |
| 2015 | 3.13x | €40.38 Million | €12.90 Million | ▼ -98.6% |
| 2014 | 228.93x | €54.26 Million | €237.00K | — |
Cash Flow Quality Index = Operating Cash Flow / Net Income. Ratios above 1.0x indicate cash-backed earnings.